Cargando…

Discovery by a proteomic approach of possible early biomarkers of drug-induced nephrotoxicity in medication-overuse headache

BACKGROUND: Medication-overuse headache (MOH) is a chronic headache condition that results from the overuse of analgesics drugs, triptans, or other antimigraine compounds. The epidemiology of drug-induced disorders suggests that medication overuse could lead to nephrotoxicity, particularly in chroni...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bellei, Elisa, Monari, Emanuela, Cuoghi, Aurora, Bergamini, Stefania, Guerzoni, Simona, Ciccarese, Michela, Ozben, Tomris, Tomasi, Aldo, Pini, Luigi Alberto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3606963/ https://www.ncbi.nlm.nih.gov/pubmed/23565828 http://dx.doi.org/10.1186/1129-2377-14-6

Ejemplares similares

Validation of potential candidate biomarkers of drug-induced nephrotoxicity and allodynia in medication-overuse headache
por: Bellei, Elisa, et al.
Publicado: (2015)

Urinary Proteomics in Biomarker Discovery of Kidney-Related Disorders: Diabetic Nephropathy and Drug-Induced Nephrotoxicity in Chronic Headache
por: Bellei, Elisa, et al.
Publicado: (2018)

Proteomic analysis of urine in medication-overuse headache patients: possible relation with renal damages
por: Bellei, Elisa, et al.
Publicado: (2011)

Proteomic research of proteins involved in pain expression in an animal model of chronic pain
por: Bellei, Elisa, et al.
Publicado: (2015)

Inflammation: an important parameter in the search of prostate cancer biomarkers
por: Bergamini, Stefania, et al.
Publicado: (2014)

Serum protein changes in a rat model of chronic pain show a correlation between animal and humans
por: Bellei, Elisa, et al.
Publicado: (2017)

Exploration of candidate serum biomarkers potentially related to the chronic pain condition in Medication–overuse headache
por: Pellesi, Lanfranco, et al.
Publicado: (2019)

Discovery of restless legs syndrome plasmatic biomarkers by proteomic analysis
por: Bellei, Elisa, et al.
Publicado: (2018)

Analysis of protein expression in periodontal pocket tissue: a preliminary study
por: Monari, Emanuela, et al.
Publicado: (2015)

Nabilone for the treatment of medication overuse headache: results of a preliminary double-blind, active-controlled, randomized trial
por: Pini, Luigi Alberto, et al.
Publicado: (2012)

Enriched sera protein profiling for detection of non-small cell lung cancer biomarkers
por: Monari, Emanuela, et al.
Publicado: (2011)

Serum levels of allopregnanolone, progesterone and testosterone in menstrually-related and postmenopausal migraine: A cross-sectional study
por: Rustichelli, Cecilia, et al.
Publicado: (2020)

Comparison of pregnenolone sulfate, pregnanolone and estradiol levels between patients with menstrually-related migraine and controls: an exploratory study
por: Rustichelli, Cecilia, et al.
Publicado: (2021)

Urinary Proteomics Reveals Promising Biomarkers in Menstrually Related and Post-Menopause Migraine
por: Bellei, Elisa, et al.
Publicado: (2021)

P045. OnabotulinumtoxinA: long term treatment for chronic migraine with medication overuse
por: Guerzoni, Simona, et al.
Publicado: (2015)

Proteomic Analysis of PTCH1+/− Fibroblast Lysate and Conditioned Culture Media Isolated from the Skin of Healthy Subjects and Nevoid Basal Cell Carcinoma Syndrome Patients
por: Ponti, Giovanni, et al.
Publicado: (2013)

Long-term Treatment Benefits and Prolonged Efficacy of OnabotulinumtoxinA in Patients Affected by Chronic Migraine and Medication Overuse Headache over 3 Years of Therapy
por: Guerzoni, Simona, et al.
Publicado: (2017)

Impact of continuing or quitting smoking on episodic cluster headache: a pilot survey
por: Ferrari, Anna, et al.
Publicado: (2013)

Addendum: Long-term Treatment Benefits and Prolonged Efficacy of OnabotulinumtoxinA in Patients Affected by Chronic Migraine and Medication Overuse Headache over 3 Years of Therapy
por: Guerzoni, Simona, et al.
Publicado: (2018)

Proteomics Disclose the Potential of Gingival Crevicular Fluid (GCF) as a Source of Biomarkers for Severe Periodontitis
por: Bellei, Elisa, et al.
Publicado: (2022)

Safety and Risk of Medication Overuse Headache in Lasmiditan and Second-Generation Gepants: A Rapid Review
por: Lo Castro, Flavia, et al.
Publicado: (2021)

Galcanezumab for the treatment of chronic migraine and medication overuse headache: Real‐world clinical evidence in a severely impaired patient population
por: Guerzoni, Simona, et al.
Publicado: (2023)

A Proteomic Analysis of Discolored Tooth Surfaces after the Use of 0.12% Chlorhexidine (CHX) Mouthwash and CHX Provided with an Anti-Discoloration System (ADS)
por: Bergamini, Stefania, et al.
Publicado: (2021)

Detoxification vs non-detoxification before starting an anti-CGRP monoclonal antibody in medication overuse headache
por: Pensato, Umberto, et al.
Publicado: (2022)

Basal cutaneous pain threshold in headache patients
por: Zappaterra, Maurizio, et al.
Publicado: (2011)

Medication-overuse headache: an update
por: Sarchielli, Paola
Publicado: (2015)

Research of Prostate Cancer Urinary Diagnostic Biomarkers by Proteomics: The Noteworthy Influence of Inflammation
por: Bellei, Elisa, et al.
Publicado: (2023)

Withdrawal failure in patients with chronic migraine and medication overuse headache
por: D’Amico, Domenico, et al.
Publicado: (2021)

Medication–overuse headache: pathophysiological insights
por: Calabresi, P., et al.
Publicado: (2005)

Medication-overuse headache: a review
por: Kristoffersen, Espen Saxhaug, et al.
Publicado: (2014)

Preventing and treating medication overuse headache
por: Alstadhaug, Karl B., et al.
Publicado: (2017)

Comparison of tolerability and efficacy of a combination of paracetamol + caffeine and sumatriptan in the treatment of migraine attack: a randomized, double-blind, double-dummy, cross-over study
por: Pini, Luigi Alberto, et al.
Publicado: (2012)

Management of medication overuse (MO) and medication overuse headache (MOH) S1 guideline
por: Diener, Hans-Christoph, et al.
Publicado: (2022)

Therapeutical approaches to paroxysmal hemicrania, hemicrania continua and short lasting unilateral neuralgiform headache attacks: a critical appraisal
por: Baraldi, Carlo, et al.
Publicado: (2017)

Lack of association between five serotonin metabolism-related genes and medication overuse headache
por: Cevoli, Sabina, et al.
Publicado: (2009)

Medication-overuse headache: citalopram associated with analgesics withdrawal as possible treatment
por: Moretti, Rita, et al.
Publicado: (2003)

Abnormal cortical responses to somatosensory stimulation in medication-overuse headache
por: Coppola, Gianluca, et al.
Publicado: (2010)

Chronic Migraine and Medication Overuse Headache Worsening After OnabotulinumtoxinA Withdrawn Due to the Severe Acute Respiratory Syndrome-Coronavirus-2 Pandemic
por: Baraldi, Carlo, et al.
Publicado: (2021)

Treatment and outcome in medication overuse headache patients
por: Mitsikostas, D, et al.
Publicado: (2013)

EHMTI-0303. Treatment of medication overuse headache
por: Madsen, SK, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_u22vqhnsid8r2bjtkksksnmi9m